Dr Gan See Khem Executive Chairman and Managing Director
Date of first appointment as a Director: 26 January 1999
Date of appointment as Managing Director: 1 July 1999
Date of last re-appointment as a Director: n/a
Length of service as a Director (as at 30 June 2018): 19 years 5 months
Dr Gan See Khem is the Executive Chairman and Managing Director of Health Management International Ltd (“HMI Group”). She has been instrumental in spearheading the Group’s healthcare and education businesses since 1999.
Dr Gan is an active figure in public services and currently serves on the Malaysia-Singapore Business Council. She served as the first woman President of the Singapore Gan Clan Association and is distinguished as one of the first two women to become a council member at the Singapore Chinese Chamber of Commerce and Industry in 1995. Dr Gan is a former Nominated Member of Parliament of the Republic of Singapore. Dr Gan’s many achievements were also recently highlighted in the Women Entrepreneur Awards 2018, where she was recognized as the SuperNova Women Entrepreneur of Year 2018.
She was also previously on the Board of Trustees of the Institute of South East Asian Studies and Singapore Management University (“SMU”), and was a member of the International Advisory Board of Curtin Business School. In 2015, Dr Gan received the SG50 Outstanding Chinese Business Pioneers Award from the Singapore Chinese Chamber of Commerce and Industry. Dr Gan specialised in strategic planning and management during her 15-year tenure at the National University of Singapore.
She holds a PhD in Business Administration from the University of Sheffield, United Kingdom.
Ms Chin Wei Jia Executive Director and Group Chief Executive Officer
Date of first appointment as a Director: 28 October 2014
Date of appointment as Group CEO: 30 September 2015
Date of last re-appointment as a Director: 30 October 2017
Length of service as a Director (as at 30 June 2018): 3 years 8 months
Ms Chin Wei Jia was appointed as an Executive Director of HMI Group in October 2014 and as Group Chief Executive Officer (“CEO”) of HMI Group in September 2015. As Group CEO, she oversees and leads the strategic and operational activities of the Group. She is also the Managing Director of Mahkota Medical Centre (“Mahkota”) and Regency Specialist Hospital (“Regency”).
Ms Chin first joined HMI Group in 2002 and has played a key role in the development of HMI Group into a SGX mainboard listed healthcare company. She had contributed to the start of HMI Group’s education business via the launch of HMI Institute. Ms Chin was also a member of the core team that first commissioned Regency in 2008, and previously served as CEO of Regency from 2013 to 2016. Ms Chin recently spearheaded the Group’s entry into the Singapore private healthcare sector with the establishment of StarMed Specialist Centre, Singapore’s latest one-stop ambulatory care centre.
She is a member of the Malaysia-Singapore Business Council.
Ms Chin holds a Bachelor of Arts (summa cum laude) in Economics and International Relations from Boston University, USA. She also has a Masters of Arts in International Relations from Johns Hopkins University, USA. Ms Chin is the daughter of the Executive Chairman, Dr Gan See Khem and the sister of the Group Chief Investment Officer, Mr Chin Wei Yao.
Mr Chin Wei Yao Executive Director & Chief Investment Officer
Date of first appointment as a Director: 23 October 2015
Date of last re-appointment as a Director: 24 October 2016
Length of service as a Director (as at 30 June 2018): 2 years 8 months
Mr Chin Wei Yao was appointed as an Executive Director of HMI Group in October 2015, and as Chief Investment Officer with effect from February 2019. As Chief Investment Officer, Mr Chin is responsible for driving the development of the Group’s healthcare services business in the region through partnerships and strategic investments. Since joining the Group in 2015, Mr Chin has led various corporate initiatives such as the consolidation of non-controlling interests at Mahkota Medical Centre and Regency Specialist Hospital, acquisition of a controlling stake in StarMed Specialist Centre, and the investment in Plus Medical Holdings, a chain of primary care clinics in Singapore. Mr Chin is also an Executive Director of Mahkota.
Mr Chin started out his career as an investment banker at Credit Suisse in 2007. Prior to joining HMI Group, Mr Chin worked for 8 years in private equity and investment banking in South East Asia. His last position was Associate Director at KV Asia Capital where he was responsible for investment execution and portfolio management. He was previously a Vice President at Sindicatum Sustainable Resources Group where he oversaw a portfolio of clean energy investments.
Mr Chin holds a Bachelor of Arts (summa cum laude) in Economics (Honours) from New York University, USA. He is also an affiliate member of the Association Chartered Certified Accountants (“ACCA”). Mr Chin is the son of the Executive Chairman, Dr Gan See Khem and the brother of the Group Chief Executive Officer, Ms Chin Wei Jia.
Dr Cheah Way Mun Non-Executive Director, Independent
Date of first appointment as a Director: 8 September 1999
Date of last re-appointment as a Director: 30 October 2017
Length of service as a Director (as at 30 June 2018): 18 years 9 months
Dr Cheah Way Mun is an Independent Non-Executive Director of HMI Group. He is also a member of the Remuneration Committee and Nominating Committee of HMI Group.
Dr Cheah is an accomplished ophthalmic surgeon in private practice. He was previously the head of the eye department of Tan Tock Seng Hospital and a visiting consultant of the National University Hospital and the Singapore National Eye Centre.
Dr Cheah holds an MBBS from the then University of Singapore and is a fellow of the Royal College of Surgeons (Glasgow and Edinburgh) and the American Academy of Ophthalmology.